open access

Vol 2, No 5 (2013)
Review
Published online: 2013-10-25
Get Citation

What is known about diabetogenic effects of statins?

Longina Kłosiewicz-Latoszek, Barbara Cybulska
Diabetologia Kliniczna 2013;2(5):178-184.

open access

Vol 2, No 5 (2013)
Review
Published online: 2013-10-25

Abstract

Since some time the evidence has been accumulated on the diabetogenic effects of statins. These findings from clinical and observational studies are spread between doctors and patients, and part of them may be afraid to prescribe or take these drugs. In this situation we have recognized that real knowledge on this side effect of statins is of importance, especially that they are widely used because well-established clinical benefit in cardiovascular disease prevention. In the article authors have described the results of clinical studies and meta-analyses, as well as possible mechanisms by which statin therapy may cause diabetes (impaired pancreatic β cell insulin secretion and increasing insulin resistance). In conclusion it should be stressed that however statins may worsen glucose metabolism, especially in susceptible population (women, elderly people, and presence of metabolic syndrome elements) their cardiovascular benefi t outweigh the risk of diabetes development. This statins are still recommended for cardiovascular event prevention as the drug of choice. However the monitoring the fasting glucose should be considered in the people who are at risk of diabetes.

Abstract

Since some time the evidence has been accumulated on the diabetogenic effects of statins. These findings from clinical and observational studies are spread between doctors and patients, and part of them may be afraid to prescribe or take these drugs. In this situation we have recognized that real knowledge on this side effect of statins is of importance, especially that they are widely used because well-established clinical benefit in cardiovascular disease prevention. In the article authors have described the results of clinical studies and meta-analyses, as well as possible mechanisms by which statin therapy may cause diabetes (impaired pancreatic β cell insulin secretion and increasing insulin resistance). In conclusion it should be stressed that however statins may worsen glucose metabolism, especially in susceptible population (women, elderly people, and presence of metabolic syndrome elements) their cardiovascular benefi t outweigh the risk of diabetes development. This statins are still recommended for cardiovascular event prevention as the drug of choice. However the monitoring the fasting glucose should be considered in the people who are at risk of diabetes.
Get Citation

Keywords

statins, risk of diabetes, possible pathomechanisms

About this article
Title

What is known about diabetogenic effects of statins?

Journal

Clinical Diabetology

Issue

Vol 2, No 5 (2013)

Pages

178-184

Published online

2013-10-25

Bibliographic record

Diabetologia Kliniczna 2013;2(5):178-184.

Keywords

statins
risk of diabetes
possible pathomechanisms

Authors

Longina Kłosiewicz-Latoszek
Barbara Cybulska

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Diabetologia Kliniczna dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl